These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 31894361)

  • 1. The dark side of Alzheimer's disease: unstructured biology of proteins from the amyloid cascade signaling pathway.
    Gadhave K; Gehi BR; Kumar P; Xue B; Uversky VN; Giri R
    Cell Mol Life Sci; 2020 Oct; 77(20):4163-4208. PubMed ID: 31894361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dark proteome of cancer: Intrinsic disorderedness and functionality of HIF-1α along with its interacting proteins.
    Garg N; Kumar P; Gadhave K; Giri R
    Prog Mol Biol Transl Sci; 2019; 166():371-403. PubMed ID: 31521236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic disorder in proteins associated with oxidative stress-induced JNK signaling.
    Gehi BR; Gadhave K; Uversky VN; Giri R
    Cell Mol Life Sci; 2022 Mar; 79(4):202. PubMed ID: 35325330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
    Cho JE; Kim JR
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant accrual of BIN1 near Alzheimer's disease amyloid deposits in transgenic models.
    De Rossi P; Andrew RJ; Musial TF; Buggia-Prevot V; Xu G; Ponnusamy M; Ly H; Krause SV; Rice RC; de l'Estoile V; Valin T; Salem S; Despa F; Borchelt DR; Bindokas VP; Nicholson DA; Thinakaran G
    Brain Pathol; 2019 Jul; 29(4):485-501. PubMed ID: 30506549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Amyloid Hypothesis in Alzheimer's Disease.
    Paroni G; Bisceglia P; Seripa D
    J Alzheimers Dis; 2019; 68(2):493-510. PubMed ID: 30883346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO and Alzheimer's disease.
    Lee L; Sakurai M; Matsuzaki S; Arancio O; Fraser P
    Neuromolecular Med; 2013 Dec; 15(4):720-36. PubMed ID: 23979993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of β cleavage of amyloid precursor protein.
    Wang JF; Lu R; Wang YZ
    Neurosci Bull; 2010 Oct; 26(5):417-27. PubMed ID: 20882069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Linking Mass Spectrometry Analysis of Metastable Compact Structures in Intrinsically Disordered Proteins.
    Chen D; Joachimiak LA
    Methods Mol Biol; 2023; 2551():189-201. PubMed ID: 36310204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease.
    Ma WH; Chen AF; Xie XY; Huang YS
    Neuropharmacology; 2021 Jun; 190():108342. PubMed ID: 33045243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.